ATE234865T1 - Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom - Google Patents

Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom

Info

Publication number
ATE234865T1
ATE234865T1 AT95902920T AT95902920T ATE234865T1 AT E234865 T1 ATE234865 T1 AT E234865T1 AT 95902920 T AT95902920 T AT 95902920T AT 95902920 T AT95902920 T AT 95902920T AT E234865 T1 ATE234865 T1 AT E234865T1
Authority
AT
Austria
Prior art keywords
peptide
peptil
sythetic
medicine
novel
Prior art date
Application number
AT95902920T
Other languages
English (en)
Inventor
Tsunetomo Takei
Eiji Ohtsubo
Hirosi Ohkawa
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE234865T1 publication Critical patent/ATE234865T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
AT95902920T 1993-12-08 1994-12-07 Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom ATE234865T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30765793 1993-12-08
PCT/JP1994/002057 WO1995015980A1 (fr) 1993-12-08 1994-12-07 Nouveau peptide synthetique, tensioactif pulmonaire contenant ledit peptide et remede contre le syndrome de souffrance respiratoire

Publications (1)

Publication Number Publication Date
ATE234865T1 true ATE234865T1 (de) 2003-04-15

Family

ID=17971685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902920T ATE234865T1 (de) 1993-12-08 1994-12-07 Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom

Country Status (22)

Country Link
US (1) US5827825A (de)
EP (1) EP0733645B1 (de)
JP (1) JP3644035B2 (de)
KR (1) KR100342806B1 (de)
CN (1) CN1057099C (de)
AT (1) ATE234865T1 (de)
AU (1) AU682738B2 (de)
BG (1) BG62777B1 (de)
CA (1) CA2178345A1 (de)
CZ (1) CZ162396A3 (de)
DE (1) DE69432313T2 (de)
DK (1) DK0733645T3 (de)
ES (1) ES2189825T3 (de)
FI (1) FI962355A (de)
HU (1) HU215933B (de)
NO (1) NO962403L (de)
NZ (1) NZ277095A (de)
PL (1) PL180020B1 (de)
PT (1) PT733645E (de)
RO (1) RO118298B1 (de)
SK (1) SK71496A3 (de)
WO (1) WO1995015980A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2576895A (en) * 1994-12-07 1996-06-26 Tokyo Tanabe Company Limited Intermediate for producing surfactant peptide
WO1997035882A1 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
JPH11217397A (ja) * 1997-11-27 1999-08-10 Saburo Aimoto ペプチドチオールエステルの製造方法
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
BR9906091A (pt) * 1999-12-22 2002-06-04 Conselho Nacional Cnpq Usos de resina de troca aniÈnica (epm-7) como suporte sólido para a sìntese peptìdica e para cromatografia de afinidade
US6998384B2 (en) * 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ES2295961T3 (es) * 2003-12-31 2008-04-16 F. Hoffmann-La Roche Ag Proceso para la sintesis peptidica utilizacndo una cantidad reducida de agente de desproteccion.
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
JPWO2005105111A1 (ja) 2004-04-29 2008-07-31 相男 李 人工肺サーファクタント組成物およびその使用方法
KR100635541B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
AU2006203978B2 (en) 2005-01-06 2011-11-03 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (de) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetische Lungensurfactant-Peptide
EP2281574B1 (de) 2008-04-02 2014-07-09 The University of Tokushima Antigen-und-arznei-vehikel mit einem synthetischen peptid und dieses verwendender mukosaler impfstoff
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290516A4 (de) * 1986-10-24 1989-11-14 Jeffrey A Whitsett Proteine, die mit oberflächenwirksamen hydrophoben lungenwirkstoffen verbunden sind.
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
JP2602968B2 (ja) * 1987-11-04 1997-04-23 カリフォルニア バイオテクノロジー インコーポレイテッド 肺胞の界面活性タンパク類
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
EP0733645B1 (de) 2003-03-19
FI962355A0 (fi) 1996-06-06
RO118298B1 (ro) 2003-04-30
HUT74880A (en) 1997-02-28
EP0733645A4 (de) 1998-12-09
EP0733645A1 (de) 1996-09-25
HU9601563D0 (en) 1996-08-28
SK71496A3 (en) 1996-11-06
KR100342806B1 (ko) 2002-11-29
AU682738B2 (en) 1997-10-16
HU215933B (hu) 1999-03-29
CZ162396A3 (en) 1996-10-16
DK0733645T3 (da) 2003-07-14
JP3644035B2 (ja) 2005-04-27
DE69432313T2 (de) 2003-10-16
NO962403D0 (no) 1996-06-07
KR960706507A (ko) 1996-12-09
CA2178345A1 (en) 1995-06-15
PT733645E (pt) 2003-07-31
BG100554A (bg) 1996-12-31
DE69432313D1 (de) 2003-04-24
BG62777B1 (bg) 2000-07-31
FI962355A (fi) 1996-06-06
US5827825A (en) 1998-10-27
AU1199295A (en) 1995-06-27
PL180020B1 (en) 2000-12-29
WO1995015980A1 (fr) 1995-06-15
CN1136813A (zh) 1996-11-27
CN1057099C (zh) 2000-10-04
NO962403L (no) 1996-06-07
ES2189825T3 (es) 2003-07-16
NZ277095A (en) 1997-09-22
PL314872A1 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
ATE234865T1 (de) Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom
CA2191344A1 (en) Synthetic peptide analogs of lung surfactant protein sp-c
FI893750A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
ES2110997T3 (es) 1,2,5,6-tetrahidro-1-metilpiridinas, su preparacion y uso.
ES2052947T3 (es) Nueva forma unitaria, solida y porosa que comprende microparticulas y/o nanoparticulas asi como su preparacion.
KR960701049A (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)
DK193887D0 (da) Fysiologisk aktivt peptid
IT1212900B (it) Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
CA2189947A1 (en) Use of von willebrand factor and pharmaceutical formulation
FI903280A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 1-/4,5-dihydroksi-N2-(10,12-dimetyyli-1-oksotetradekyyli)ornitiini/-5-(3-hydroksiglutamiini)-6-(3-hydroksiproliini)ekinokandiini B:n valmistamiseksi
NO924578L (no) Ny taurinbasert farmasoeytisk blanding for administrering ved inhalasjon
FI962967A0 (fi) Menetelmä aerosolin valmistamiseksi
IL95892A0 (en) Aroyl-ureas,their preparation and pharmaceutical compositions containing them
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
SE8800182L (sv) Anvaendning av alkylglycerol foer framstaellning av ett laekemedel
ES2074714T3 (es) Compuestos aciclicos o azabiciclicos, su preparacion y uso.
UA19456C2 (uk) СПОСІБ ВИДІЛЕHHЯ beta-МЕТИЛHАФТАЛІHУ ІЗ СИРОВИHИ З ПІДВИЩЕHИМ ВМІСТОМ HАСИЧЕHИХ ВУГЛЕВОДHІВ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0733645

Country of ref document: EP

REN Ceased due to non-payment of the annual fee